ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

ZYNE Zynerba Pharmaceuticals Inc

1.30
0.00 (0.00%)
02 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Zynerba Pharmaceuticals Inc ZYNE 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 1.30 09:00:00
개장가 저가 고가 종가 전일 종가
1.30 1.30
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
09/02/202409:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
20/10/202305:48EDGAR2Form 15-12G - Securities registration termination [Section..
12/10/202313:15EDGAR2Form EFFECT - Notice of Effectiveness
11/10/202323:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202323:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202323:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202323:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202322:27EDGAR2Form POS AM - Post-Effective amendments for registration..
11/10/202322:27EDGAR2Form S-8 POS - Securities to be offered to employees in..
11/10/202321:56EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
11/10/202321:31EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
11/10/202321:17EDGAR2Form 8-K - Current report
11/10/202321:00PRNUSHARMONY BIOSCIENCES COMPLETES ACQUISITION OF ZYNERBA..
05/10/202306:29EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
05/10/202305:05GLOBEImportant Information for Zynerba Pharmaceuticals..
29/09/202322:00GLOBEZynerba Pharmaceuticals Stockholders Reminded to Tender..
27/09/202321:25EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
27/09/202321:12EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
27/09/202321:00PRNUSHARMONY BIOSCIENCES ANNOUNCES EXTENSION OF TENDER OFFER TO..
15/09/202321:00EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
15/09/202305:59EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
15/09/202305:16EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
15/09/202305:15GLOBEZynerba Pharmaceuticals Presents Positive Data from Phase 2..
15/09/202305:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/09/202305:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/09/202305:39EDGAR2Form SC 13G - Statement of acquisition of beneficial..
30/08/202305:05EDGAR2Form 8-K - Current report
28/08/202322:05EDGAR2Form SC 14D9 - Solicitation, recommendation statements
28/08/202321:23EDGAR2Form SC TO-T - Tender offer statement by Third Party
25/08/202306:23EDGAR2Form SC 13D - General statement of acquisition of beneficial..
16/08/202305:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
15/08/202306:29EDGAR2Form SC TO-C - Written communication relating to an issuer..
15/08/202306:26EDGAR2Form SC TO-C - Written communication relating to an issuer..
15/08/202306:20EDGAR2Form SC14D9C - Written communication relating to third party..
14/08/202320:45EDGAR2Form SC14D9C - Written communication relating to third party..
14/08/202320:42EDGAR2Form 8-K - Current report
14/08/202320:36EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/08/202320:30PRNUSHARMONY BIOSCIENCES TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC.
09/08/202305:13EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
09/08/202305:05GLOBEZynerba Pharmaceuticals Announces New Date for Reconvened..
26/07/202306:24EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
26/07/202306:18GLOBEZynerba Pharmaceuticals Announces New Date for Reconvened..
29/06/202305:21EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
29/06/202305:05GLOBEZynerba Pharmaceuticals Announces Further Adjournment of..
20/06/202320:00GLOBEZynerba Pharmaceuticals to Present at the H.C. Wainwright..
14/06/202305:05GLOBEZynerba Pharmaceuticals Announces Partial Adjournment of..
23/05/202320:00GLOBEZynerba Pharmaceuticals Announces Podium and Poster..
15/05/202320:00GLOBEZynerba Pharmaceuticals Reports First Quarter 2023 Financial..

최근 히스토리

Delayed Upgrade Clock